Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
|
Outline of Final Research Achievements |
The molecule which specifically expressed for malignant tumors of the field of gynecology and obstetrics was screened. We carried out close inspection in mind in possibilities of the clinical application continuously. In 2018, we identified the molecule which specifically expressed for gynecologic cancer. The molecule expressed with various tissues of ovarian cancer. After the approval of the Ethical Review Board, we are investigating whether it can be the biomarker.
|